# PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas

> **NCT05190172** · NA · RECRUITING · sponsor: **Oslo University Hospital** · enrollment: 225 (estimated)

## Conditions studied

- Oligodendroglioma
- Oligodendroglioma, Anaplastic
- Diffuse Astrocytoma, IDH-Mutant

## Interventions

- **RADIATION:** Radiation therapy

## Key facts

- **NCT ID:** NCT05190172
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-14
- **Primary completion:** 2030-12-31
- **Final completion:** 2045-12-31
- **Target enrollment:** 225 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05190172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05190172, "PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT05190172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*